Stonepine Capital Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
A detailed history of Stonepine Capital Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 250,000 shares of MIST stock, worth $450,000. This represents 0.19% of its overall portfolio holdings.
Number of Shares
250,000
Previous 500,000
50.0%
Holding current value
$450,000
Previous $1.18 Billion
83.05%
% of portfolio
0.19%
Previous 0.95%
Shares
5 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$8.95 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.51 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.61 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.57 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2.04 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $54M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...